cancer cells, enables them to evade apoptosis. The mutations in cancer cells can also change the normal function of the telomerase, thus give rise to cancer cell a limitless replicative potential (Bree et al. 2002; Kim et al. 1994 ). Tumour invasion, metastasis and angiogenesis play important roles in allowing the progression of a malignant tumour, by escaping the primary site, invading into blood or lymph circulation, migration to a distant site and finally establishing a secondary tumour. 
Prostate cancer
Prostate is a gland in the male reproductive system that is responsible for the production and storage of seminal fluid. The normal adult human prostate is about the walnut size and is located at the neck of the urinary bladder and surrounds part of the urethra. Prostate cancer develops when its semen-secreting prostate gland cells are transformed into cancer cells, and has been classified as adenocarcinoma. Prostate cancer is one of the most commonly diagnosed cancers in men and it is the second leading cause of cancer death after lung cancer worldwide. The incidence and mortality rates of prostate cancer are increasing in Asia as well as in the United States over the past few decades (National Cancer Institute [NCI], 2011).
Symptoms & diagnosis
Prostate cancer will cause male patients to experience difficulties during urination such as nocturia, hematuria, dysuria, and will also interfere with sexual functions and performance. The high mortality rate in prostate cancer patients is due to late detection as prostate cancer is usually asymptomatic or the symptoms appear only during the advanced stage of disease. About 50% of prostate cancer patients are usually diagnosed with bone metastasis. 
Stages
It is important to determine the stage of prostate tumour in order to plan an effective treatment in patient (Table 2 ). This is because there is a differential response to treatment in the different stages of this cancer. To determine accurately the stage of prostate tumour in patients, different tests are conducted and all information will be gathered from CT (computerised tomography) scan, MRI (magnetic resonance imaging), PSA (prostate-specific antigen) test and tumour biopsy (NCI, 2011).
Stage Description

I
Cancer cells are found in prostate gland only and PSA < 10
II
IIA IIA
Divided to 2 categories; Found in one half or less than one lobe and PSA < 20 Found in both lobes of prostate gland and PSA < 20
III
Spread beyond the outer layer of prostate gland and may spread to seminal vesicle, PSA value is ranging from 2-10.
IV
Spread to nearby or other organs such as rectum, bladder and bone, any level in PSA Table 2 . Stages of prostate tumour (Source: NCI, USA)
Treatments
Currently, there are four standard treatments for prostate cancer; watchful waiting, surgery, radiation therapy and hormone therapy. In watchful waiting, a patient will be closely monitored by doctors and no treatment will be given until symptoms start to appear. While in surgery, prostate gland from patients will be removed before the cancer cells are able to spread to other organs. In radiation therapy, high energy X-rays will be used to kill cancer cells. Antiandrogens, estrogens and luteinizing hormone-releasing hormone agonists, are the few examples used in hormone therapy to stop the cancer cells by disrupt their growth and/or kill them. While other treatment includes chemotherapy and proton-beam radiation therapy which are used in conjunction with other standard treatments (NCI, 2011). 
Problems
Natural products
Herbs and plants-derived medicines have a long history of use in the various treatments and now, they still remain as important sources for the development of anticancer drugs. More than 3000 plants species have been reported to be involved in the development of anticancer drugs (Shoeb, 2006) . The exploration of anticancer agents from plant sources has started since the 1950s. Since then, extensive research and investigations have been conducted and lead to the discovery and development of several anticancer agents derived from plant such as taxol, vinblastine and vincristine (Cragg & Newman, 2005 
Turmeric (curcumin)
Turmeric
Phyllanthus
The plant of the genus Phyllanthus is a small annual plant and is widely distributed throughout the tropical and subtropical regions of world (Lee et al. 1996) . This plant has a long history in medical herbalism system to treat kidney and urinary bladder disturbances. The anticancer effects of the genus Phyllanthus has been reported in a few papers, for instance P. amarus protects the liver from hepatocarcinogenesis and the root extract of P. acuminatus exerts growth inhibition in murine P-388 lymphocytic leukemia and B-16 melanoma cell lines (Pettit et al. 1990 ; Powis & Moore, 1985) . Thus, it is believed that the plant genus Phyllanthus might possess anticancer properties against prostate cancer as well. Table 3 . Most of these bioactive compounds such as gallic acid, gereniin and rutin, possess antioxidant and anticancer effects.
Bioactive compounds
Anti-proliferative effects
One of the hallmarks of cancer is uncontrolled proliferation. Thus, the anti-proliferative effect of a substance is referring to the ability of the substance to halt cancer growth by inhibiting/killing cancer cells. 
Cell cycle inhibitor
Cell is the building block of all living things in this world. The cell cycle is a critical regulator that controls proliferation and growth of a cell. Cell cycle is the series of events that leads the cells to divide and replicate. This biological process involves a sequence of molecular events to ensure correct transmission of the genetic material to subsequent generations. Error in this transmission will lead the cells to either undergo checkpoints to correct the error or cause cell death. Defects in regulation of cell cycle will lead modification (mutation) in genetics of the cell and cells which leads to tumorigenesis. An uncontrolled proliferation and the ability to evade of apoptosis by mutated (cancer) cells are the hallmarks for the development of cancer. 
Compound
Phyllanthus species References
Apoptosis inducer
There are two main cell deaths; necrotic and apoptotic processes. Apoptosis is one of the main types of programmed cell death (PCD) that occurs only in multicellular organisms to eliminate damaged or unneeded cells without local inflammation from leakage of cell contents. It does provide a balance between cell proliferation and elimination, as a part of homeostasis. Apoptosis involves a series of biochemical events, which leads to distinct characteristics of cell morphology and death such as cell shrinkage and membrane blebbing. Necrotic cell death is characterized by cellular swelling, plasma membrane rupture, cell lysis and induction of inflammation around the necrotic cells due to leakage of the intracellular contents (Chen and Wang, 2002) . Dysregulation of the apoptotic process in human body can disrupt the equilibrium between cell's growth and death and this dysregulation implicated in a variety of diseases states. Acquired immunodeficiency syndrome (AIDS) and neurodegenerative diseases such as Alzheimer's disease are examples of diseases due to acceleration of cell death rates. Conversely, an inappropriate low rate of apoptotic process can give rise to autoimmune disorders or cancer (Fadeel & Orrenius, 2005) . The genetic abnormalities of cancer cells are able bypass the apoptosis and escape from cell death. Thus, evasiveness of apoptosis is a hallmark of cancer and is critical for cancer development and the survival of a tumour cell (Vincent & Gatenby, 2008) . The regulations of apoptosis on cancer cells are always associated with caspases activation. Caspases (cysteine-aspartic proteases or cysteine-dependent aspartate-directed proteases) are a family of cysteine proteases that play essential roles in apoptosis. There are two types of apoptotic caspases: initiator and effector caspases. Initiator caspases (caspase-2, -8, -9 and -10) are responsible to activate the effector caspases which initially are in an inactive pro-form. The active effector caspases (caspase-3, -6 and -7) will in turn cleave other proteins to initiate the apoptotic process to occur. In addition, these caspases will also activate other degradative enzymes such as DNases, which cleave the DNA into fragments in an apoptotic cell. 
Anti-metastatic effect
Once cancer cells have transformed into malignant, they would have acquire metastatic in which the cells can detach from primary tumour and spread to other parts of the human body. Metastasis of cancer cells involves multistep processes and various cytophysiological changes, including disruption to adhesion interaction between cancer cells and the extracellular matrix (ECM) components. It also involves an over expression of proteolytic enzymes, such as matrix metalloproteinases (MMPs), which have the capability to degrade ECM components in the basal membrane of blood vessels. This allows the cancer cells to migrate and invade via the blood or lymphatic system into target organs and lead to the development of secondary tumours (Auerbach, 2000) . Therapeutic intervention strategies to prevent metastasis have an impact on cancer mortality. However, development of these therapies are requires a better understanding and knowledge in the biology and molecular events of the metastasis process. To achieve this, various of assays been conducted based on molecular events of tumour metastasis in human body. Table 4 . Inhibition on MMP members by different Phyllanthus species
Anti-angiogenesis effects
Angiogenesis is a process by where a new blood vessel is formed from pre-existing blood vessels. It is a normal and vital process in humans' growth and development, such as wound healing. In cancer, angiogenesis plays an essential role to its growth and development. In normal circumstances, solid tumour's size is around 1 to 2 mm 2 and not vascularized. However, when this tumour reaches beyond the 2 mm 2 , oxygen and nutrients are hardly diffuse to the tumour and cause cellular hypoxia. This condition will lead to the onset of tumour angiogenesis (Folkman, 1971) . The balance between proangiogenic and antiangiogenic molecules is essential to maintain normal homeostasis in human body. Disruption of this balance would implicate to a variety of diseases states such as excessive (e.g. cancer and psoriasis) or inadequate (e.g. chronic wounds and stroke) angiogenesis. To date, angiogensis inhibitors have been reported to have less toxicity to normal cells and no development of drug resistance of cancer cells was notice such as bevacizumab, which been proven to improve the overall response including cancer time to progression, and survival rate. This makes the anti-angiogenic drugs highly advantageous over the conventional cytotoxic drugs. In addition, limited effectiveness of chemotherapy on advanced cancer has turn attention to these anti-angiogenic drugs and it is believed that these drugs will substitute the standard therapy (e.g. surgery, radiotherapy and chemotherapy). Endothelial cells are involved in tumour angiogenesis by forming the linings of blood vessels, however, these tumour vessels have abnormal morphologies and are in immature forms. Thus, targeting these tumour vessels can be a promising target for antiangiogenic therapy (Auerbach, 2003) . Tumour angiogenesis is critically important for tumour growth and metastasis with formation of new blood vessels to supply oxygen and nutrients to cancer cells and also to eliminate metabolic waste products (Auerbach, 2003) . Thus, both tumour metastasis and angiogenesis are major cause of morbidity and they remain a challenge in cancer treatments.
Since the relationship between angiogenesis and cancer is clearly related where inhibition of angiogenesis could suppress/restrict tumour growth, this had attracted a strong interest from researchers worldwide to search for potential compounds that could inhibit angiogenesis. Although there are some successful anti-angiogenic drugs that have been commercialized and used in clinical and some in pre-clinical testing stage, but more effective and safer approaches are still required. 
Antitumour effects
Conclusion
These findings revealed that Phyllanthus plants do possess anticancer activity in a selective manner towards cancer cells and initiate them to undergo apoptosis. The anticancer activity of Phyllanthus plant on prostate cancer cells was through its regulation on cancer cell cycle and apoptosis induction mediated via caspases activation. The anti-metastatic and antiangiogenesis effects observed in Phyllanthus plant, indicate their potential in inhibiting the development of secondary tumour. Further investigations into the mechanism of anticarcinogenic, anti-metastatic, anti-angiogenesis and apoptotic regulation properties of the herbal plant, Phyllanthus against prostate cancer cells is required. This may create an opportunity for the plants to not only be designed and developed as anticancer agents, but also as a dietary supplement for the prevention of cancer development. However, the preliminary in vitro data is insufficient and less convincing due to its limitation as all experiments are done in an artificial environment outside a human body. Thus, an in vivo study using experimental prostate cancer animal model is needed to determine the pharmacological and toxicological data as well as anti-tumour effect of Phyllanthus, to provide more information on the safe use and effectiveness of this plant.
